Results from a first-in-human phase 1B study of a complement factor H inhibitor (GT103) in patients with non-small cell lung cancer (NSCLC) Meeting Abstract

cited authors

  • Clarke, Jeffrey Melson; Stinchcombe, Tom; Gu, Lin; Mamdani, Hirva; Antonia, Scott Joseph; Simon, George R.; Sonpavde, Guru P.; Ready, Neal E.; Crawford, Jeffrey; Campa, Michael; Gottlin, Elizabeth; Bushey, Ryan; Herndon, James Emmett; Patz, Edward

Publication Date

  • June 1, 2023

webpage

published in

category

volume

  • 41

issue

  • 16